Disrupt CAD III With the Shockwave Coronary IVL System

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 431 participants.

Also called NCT03595176

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 431 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03595176
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, France, Germany, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03595176. Allocation not applicable; no masking; primary purpose treatment. Start 2019-01-09 (actual); primary completion 2020-05-07 (actual). Results posted on 2021-06-21.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Disrupt CAD III With the Shockwave Coronary IVL System
Intervention (Device)
Lithotripsy
Lead sponsor
Shockwave Medical, Inc. (class: industry)

Record details

Record id
cardio:ct-nct03595176
Content hash
281c49072aee38639966e88b7af1c9180541ba939cb7fcd7a2572fcd9820ee03